| P50 | author | Simon Redwood | Q70856598 |
| P2093 | author name string | M Cusack | |
| | J Coltart | |
| P2860 | cites work | The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 |
| | Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 |
| | Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease | Q73994849 |
| | Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries | Q77795523 |
| | Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators | Q77822644 |
| | Cardiac sympathetic denervation after transmyocardial laser revascularization | Q77990794 |
| | Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction | Q93864816 |
| | Initial results of laser-based percutaneous myocardial revascularization for angina pectoris | Q32024175 |
| | A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina | Q33502560 |
| | Predictors of risk in patients with unstable angina admitted to a district general hospital | Q33611971 |
| | Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis | Q34207431 |
| | Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty | Q34336722 |
| | A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group | Q34360479 |
| | Can C reactive protein or troponins T and I predict outcome in patients with intractable unstable angina? | Q35368235 |
| | Myocardial revascularization with laser. Preliminary findings | Q36684685 |
| | Transmyocardial laser revascularization: clinical experience with twelve-month follow-up | Q36797249 |
| | Transmyocardial laser revascularization: operative techniques and clinical results at two years | Q36798115 |
| | Histologic appearance of transmyocardial laser channels after 4 1/2 weeks | Q36799418 |
| | Histological findings after transmyocardial laser revascularization | Q36838458 |
| | Transmyocardial laser revascularization. Histological features in human nonresponder myocardium | Q36843768 |
| | Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q39522420 |
| | The pathogenesis of atherosclerosis--an update | Q39726917 |
| | George Lyman Duff memorial lecture. Persistent problems in the pathogenesis of atherosclerosis | Q40077725 |
| | C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study | Q40828366 |
| | C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction | Q40857092 |
| | Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies | Q43950275 |
| | Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators | Q44237954 |
| | Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. | Q44387297 |
| | Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction | Q44850788 |
| | Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators | Q45335057 |
| | Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research Investigators | Q45335160 |
| | C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction | Q47974191 |
| | Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 |
| | Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study | Q56945278 |
| | Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (Abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction | Q56945403 |
| | Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months | Q56945638 |
| | The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina | Q58230388 |
| | Atherosclerotic plaque caps are locally weakened when macrophages density is increased | Q67945371 |
| | Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques | Q69374705 |
| | Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study | Q69886150 |
| | Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation | Q70633277 |
| | Fibrinogen as a risk factor for stroke and myocardial infarction | Q71438059 |
| | One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non- | Q71827444 |
| | Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia | Q72344109 |
| | Haemostatic function and cardiovascular death: early results of a prospective study | Q72423400 |
| | Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology | Q72708405 |
| | Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture | Q72711418 |
| | Association of coronary plaque rupture and atherosclerotic inflammation | Q73158920 |
| | Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study | Q73368849 |
| | Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Compl | Q73585444 |
| P433 | issue | 899 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 542-546 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Postgraduate Medical Journal | Q7234294 |
| P1476 | title | Recent advances in ischaemic heart disease | |
| P478 | volume | 76 | |